-
Synthego Corporation 0 Open PositionsSynthego is a genome engineering company enabling the acceleration of life science research and development in the pursuit of improved human health. The company.... -
Syncopation Life Sciences 0 Open PositionsSyncopation Life Sciences is advancing a new generation of adoptive cell therapies for cancers, with a new focused emphasis on addressing primary mechanisms of.... -
Strateos 0 Open PositionsStrateos is a pioneer in the development of remote access laboratories and lab control software for life science discovery. Our mission is to create.... -
StemExpress 0 Open PositionsStemExpress supports cell and gene therapies, commercialization of disease specific treatments, medical research, clinical trials, precision/regenerative medicine, among other researchers and clinicians around the.... -
Staidson Biopharma 0 Open PositionsStaidson Biopharma Inc is a fast growing and expanding biopharmaceutical company, located in San Francisco bay area. The company is dedicated to developing novel.... -
Spotlight Therapeutics 0 Open PositionsSpotlight Therapeutics is a venture funded early-stage biotechnology company with a mission to develop a new class of therapeutics by enabling direct in vivo.... -
Specific Diagnostics 0 Open PositionsBloodstream infection leading to sepsis is responsible for more than half of all deaths in hospitals and is the most expensive condition treated in.... -
Soteria Biotherapeutics 0 Open PositionsSoteria is developing a next generation of conditionally active bispecific t-cell engaging antibodies to treat cancer patients with solid tumors. Soteria’s highly innovative T-LITE™.... -
Sonoma Biotherapeutics 0 Open PositionsSonoma Biotherapeutics is inventing the future of living therapies for autoimmune disease — safe, effective treatments as unique as each individual patient. Regulatory T.... -
Sofinnova Investments 0 Open PositionsSince our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade.....
